drugset / Trial / NCT00167245
Topiramate for Alcohol and Cocaine Dependence
Phase 2
Completed
170 enrolled
Kyle Kampman
National Institute on Alcohol Abuse and Alcoholism (NIAAA) · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The primary purpose of this study is to test the effectiveness of topiramate for the treatment of combined alcohol and cocaine dependence. Topiramate is approved for the treatment of seizures. It has not been proven to be effective for the treatment of alcohol or cocaine dependence.
Timeline
- Start
- 2004-09
- Primary completion
- 2010-03
- Completion
- 2010-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Topiramate | Small molecule | 300 mg | — |